Simplex Trading’s Entera Bio ENTX Stock Holding History

Simplex Trading’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-69	Closed	–	–	8922
2025 Q3	$0	Buy	+69	New	+$132	﹤0.01%	9292
2024 Q3	–	Sell	-260	Closed	-$461	–	8755
2024 Q2	$0	Sell	260 -35	-12%	-$77	﹤0.01%	9027
2024 Q1	$0	Buy	+295	New	+$326	﹤0.01%	9091
2023 Q4	–	Sell	-86	Closed	-$59	–	9032
2023 Q3	$0	Sell	86 -13	-13%	-$10	﹤0.01%	8939
2023 Q2	$0	Buy	+99	New	+$85	﹤0.01%	9206
2022 Q2	–	Sell	-230	Closed	-$511	–	10206
2022 Q1	$0	Sell	230 -682	-75%	-$1.64K	﹤0.01%	10626
2021 Q4	$2K	Sell	912 -18,529	-95%	-$69.4K	﹤0.01%	9975
2021 Q3	$122K	Buy	19,441 +3,699	+23%	+$19K	﹤0.01%	6332
2021 Q2	$94K	Buy	+15,742	New	+$58.2K	﹤0.01%	6820

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFCM

Seven Fleet Capital Management Mountain View, California $318M AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading's ENTX Position: Q4 2025 in Review

Simplex Trading sold out of Entera Bio (ENTX) in Q4 2025, closing a stake of 69 shares.

Simplex Trading first reported a position in ENTX in Q2 2021 and held it in 9 quarters. The position peaked at $122K in Q3 2021. 22 funds tracked by Wall St. Rank hold ENTX as of Q4 2025.

Simplex Trading reported no remaining Entera Bio position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 69 Entera Bio shares in Q4 2025.
Simplex Trading first reported a position in Entera Bio in Q2 2021 and held it in 9 quarters.
Simplex Trading's Entera Bio position peaked at $122K in Q3 2021.
22 funds tracked by Wall St. Rank held Entera Bio as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.